Compound ID | 143
Class: Small molecule antibacterial agent
| Agent Type: | Synthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | Lipopolysaccharide synthesis inhibitor. LpxC inhibitor |
| Institute where first reported: | Achaogen, USA |
| Year first mentioned: | 2012 |
| Highest developmental phase: | Phase 1 |
| Development status: | Discontinued |
| Reason Dropped: | Toxicity |
| Chemical structure(s): | |||||||||||
|
|